Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3-4
pubmed:dateCreated
2008-10-30
pubmed:abstractText
Combination therapy recently emerged as a potential therapeutic option in order to improve cardiovascular risk in diabetics, since therapies commonly used in monotherapy failed in significantly optimizing this risk.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adiponectin, http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, http://linkedlifedata.com/resource/pubmed/chemical/Dietary Fats, http://linkedlifedata.com/resource/pubmed/chemical/Heptanoic Acids, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA..., http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Insulin, http://linkedlifedata.com/resource/pubmed/chemical/Lipids, http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles, http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides, http://linkedlifedata.com/resource/pubmed/chemical/atorvastatin
pubmed:status
MEDLINE
pubmed:issn
1043-6618
pubmed:author
pubmed:issnType
Print
pubmed:volume
58
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
208-14
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:18692137-Adiponectin, pubmed-meshheading:18692137-Animals, pubmed-meshheading:18692137-Biological Markers, pubmed-meshheading:18692137-Blood Glucose, pubmed-meshheading:18692137-Body Weight, pubmed-meshheading:18692137-Cholesterol, pubmed-meshheading:18692137-Diabetes Mellitus, Type 2, pubmed-meshheading:18692137-Dietary Fats, pubmed-meshheading:18692137-Drug Synergism, pubmed-meshheading:18692137-Eating, pubmed-meshheading:18692137-Heptanoic Acids, pubmed-meshheading:18692137-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:18692137-Hyperlipidemias, pubmed-meshheading:18692137-Hypoglycemic Agents, pubmed-meshheading:18692137-Inflammation, pubmed-meshheading:18692137-Insulin, pubmed-meshheading:18692137-Insulin Resistance, pubmed-meshheading:18692137-Lipids, pubmed-meshheading:18692137-Mitochondria, Heart, pubmed-meshheading:18692137-Mitochondrial Swelling, pubmed-meshheading:18692137-Oxidative Stress, pubmed-meshheading:18692137-Perfusion, pubmed-meshheading:18692137-Pyrroles, pubmed-meshheading:18692137-Rats, pubmed-meshheading:18692137-Triglycerides
pubmed:articleTitle
Therapeutic association of atorvastatin and insulin in cardiac ischemia: study in a model of type 2 diabetes with hyperlipidemia.
pubmed:affiliation
Institute of Physiology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal. paulomatafome@gmail.com
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't